Poolbeg Pharma FY Results:“ we’ve selected our development processes to be very cost efficient”
Listen now
Description
Jeremy Skillington, CEO of Poolbeg Pharma (POLB) talks Vox Markets through a landmark year that has seen the innovative biopharma company make huge strides progressing its treatments, opening up new markets, and strengthening its team - all whilst retaining its strong balance sheet thanks to disciplined capital allocation.
More Episodes
On today's Exchange, I was delighted to speak to accomplished investor Leon Boros – including:
00:00 His long term portfolio returns.
01:25 Possible market impact of the UK general election.
04:20 Journeo plc
07:20 Hargreaves Lansdown
13:45 AJ Bell Investcentre
16:25 Spectra Systems Corporation...
Published 06/14/24
Published 06/14/24
Vox Markets talks to Dr Ilian Iliev, CEO of deep tech and life sciences investor NetScientific, about a milestone year for the group which saw it break through the £100m AUM barrier.
Published 06/13/24
Links
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
